文献速递围术期管理与 ERAS急腹症与外科感染

非甾体抗炎药与围术期手术出血相关性的系统综述与荟萃分析

Systematic Review and Meta-Analysis of the Association Between Non-Steroidal Anti-Inflammatory Drugs and Operative Bleeding in the Perioperative Period.
PubMed 文献 · J Am Coll Surg · 2021-01-27

该系统综述与荟萃分析检索MEDLINE和EMBASE,纳入1987至2019年间74篇文献共151,031例患者,评估围术期使用NSAIDs与手术出血并发症的关系。结果显示NSAIDs组与非NSAIDs组在血肿、因出血重返手术室和输血风险上均无差异(P分别为0.49、0.79、0.49)。结论认为NSAIDs不太可能是术后出血并发症的原因。

要点

  • 围术期使用NSAIDs未增加血肿、因出血重返手术室或输血风险。
  • 证据覆盖12种NSAIDs和多种手术类型,超过半数研究为随机对照试验。
  • 纳入研究质量评分范围12至25分(总分27),平均16分。

核心结论

  • NSAIDs不太可能是术后出血并发症的原因,该结论在大量患者和不同NSAIDs类型及手术类型中保持一致。

研究设计与样本

  • 由医生-图书馆员团队检索MEDLINE和EMBASE,限英文文献,最终纳入74篇1987至2019年的文献,共151,031例患者。
  • 纳入研究覆盖12种NSAIDs(最常见为酮咯酸、双氯芬酸和布洛芬)及耳鼻喉、乳腺、腹部、整形等多种手术,超过半数为随机对照试验。

主要发现

  • 荟萃分析显示NSAIDs组与非NSAIDs组在血肿风险上无差异(P=0.49)。
  • 因出血重返手术室的风险两组无差异(P=0.79)。
  • 输血风险两组无差异(P=0.49)。

关键数值与推荐

  • 血肿风险比较P=0.49,因出血重返手术室风险比较P=0.79,输血风险比较P=0.49。
  • 研究质量评分最低12分、最高25分(总分27),平均16分。

临床怎么用

  • 围术期可考虑使用NSAIDs作为非阿片类镇痛选择,而不必过度担忧术后出血并发症。

局限性

  • 纳入研究质量评分范围较宽(12至25分),提示证据质量存在异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is increasingly recognized that non-opioid analgesia is an important analgesia in the perioperative period. Specifically, NSAIDs (nonsteroidal anti-inflammatory drugs) have been touted as an adjunct, or even replacement, for opioids. However, uptake of NSAIDs has been slow due to concern for side effects, including bleeding. We sought to understand the risk of bleeding caused by NSAIDs in the perioperative period. STUDY DESIGN: A physician-librarian team performed a search of electronic databases (MEDLINE, EMBASE), using search terms covering the targeted intervention (use of NSAIDs) and outcomes of interest (surgical complications, bleeding), limited to English language articles of any date. We performed a systematic review and meta-analysis of the data. RESULTS: A total of 2,521 articles were screened, and 229 were selected on the basis of title and abstract for detailed assessment. Including reference searching, 74 manuscripts met inclusion criteria spanning years 1987-2019. These studies included 151,031 patients. Studies included 12 types of NSAIDs, the most common being ketorolac, diclofenac, and ibuprofen, over a wide-range of procedures, from otorhinolaryngology (ENT), breast, abdomen, plastics, and more. More than half were randomized control trials. The meta-analyses for hematoma, return to the operating room for bleeding, and blood transfusions showed no difference in risk in any of 3 categories studied between the NSAID vs non-NSAID groups (p = 0.49, p = 0.79, and p = 0.49, respectively). Quality scoring found a wide range of quality, with scores ranging from lowest quality of 12 to highest quality of 25, out of a total of 27 (average = 16). CONCLUSIONS: NSAIDs are unlikely to be the cause of postoperative bleeding complications. This literature covers a large number of patients and remains consistent across types of NSAIDs and operations.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Bongiovanni T, Lancaster E, Ledesma Y, et al. Systematic Review and Meta-Analysis of the Association Between Non-Steroidal Anti-Inflammatory Drugs and Operative Bleeding in the Perioperative Period. J Am Coll Surg. 2021. PMID: 33515678. doi:10.1016/j.jamcollsurg.2021.01.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。